ConductScience.org, home

Paper30697448

Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications.

Mohseni M and 2 others. Am J Blood Res, 2018. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications. Papers, record 30697448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30697448

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications.
PubMed
Journal
Am J Blood Res
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2023-10-05
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mohseni MMahsa
2Uludag HHasan
3Brandwein JMJoseph M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References231

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119164206Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.J Clin Oncol2009https://conductscience.org/library/papers/19164206PubMed
228126984Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia.Leukemia2017https://conductscience.org/library/papers/28126984PubMed
312006542
In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase.
Clin Cancer Res2002https://conductscience.org/library/papers/12006542PubMed
419109228
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Blood2009https://conductscience.org/library/papers/19109228PubMed
525645356Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.Blood2015https://conductscience.org/library/papers/25645356PubMed
628331226The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.Leukemia2017https://conductscience.org/library/papers/28331226PubMed
727121472Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.Blood2016https://conductscience.org/library/papers/27121472PubMed
811031250The Myc/Max/Mad network and the transcriptional control of cell behavior.Annu Rev Cell Dev Biol2000https://conductscience.org/library/papers/11031250PubMed
923836561Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.Blood2013https://conductscience.org/library/papers/23836561PubMed
1028821272Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia.J Hematol Oncol2017https://conductscience.org/library/papers/28821272PubMed
1127776115Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.Nat Genet2016https://conductscience.org/library/papers/27776115PubMed
1215161691Phase I study of bortezomib in refractory or relapsed acute leukemias.Clin Cancer Res2004https://conductscience.org/library/papers/15161691PubMed
1328749919Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.Clin Adv Hematol Oncol2017https://conductscience.org/library/papers/28749919PubMed
1423892718Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential.Leukemia2014https://conductscience.org/library/papers/23892718PubMed
1526497583Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells.J Hematol Oncol2015https://conductscience.org/library/papers/26497583PubMed
1615472075Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.Science2004https://conductscience.org/library/papers/15472075PubMed
1715573099Strategies to overcome resistance to targeted protein kinase inhibitors.Nat Rev Drug Discov2004https://conductscience.org/library/papers/15573099PubMed
1824553386Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.Sci Transl Med2014https://conductscience.org/library/papers/24553386PubMed
1925554682Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.Blood Cells Mol Dis2015https://conductscience.org/library/papers/25554682PubMed
2024752047
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
J Clin Oncol2014https://conductscience.org/library/papers/24752047PubMed

See all 231 referencesDownload CSV of references

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
41438983The impact of environmental contaminants, air pollution, and social deprivation on childhood leukemia survival in California.Front Oncol2025https://conductscience.org/library/papers/41438983PubMed
38348824Design, synthesis, molecular modelling and biological evaluation of novel 6-amino-5-cyano-2-thiopyrimidine derivatives as potent anticancer agents against leukemia and apoptotic inducers.J Enzyme Inhib Med Chem2024https://conductscience.org/library/papers/38348824PubMed
38065726Clinical and prognostic significance of CD27 and CD44 expression patterns in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia.Hematol Transfus Cell Ther2024https://conductscience.org/library/papers/38065726PubMed
37926559Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing.Blood Res2023https://conductscience.org/library/papers/37926559PubMed
37921440Pre- and Postnatal Exposures to Tobacco Smoking and Survival of Childhood Acute Lymphoblastic and Myeloid Leukemias in California, United States.Cancer Epidemiol Biomarkers Prev2024https://conductscience.org/library/papers/37921440PubMed
37035397Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies.Transl Pediatr2023https://conductscience.org/library/papers/37035397PubMed
36970053Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia.Cancer Res Commun2022https://conductscience.org/library/papers/36970053PubMed
36798930Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity.Transl Pediatr2023https://conductscience.org/library/papers/36798930PubMed
36226057An easy-to-use nomogram predicting overall survival of adult acute lymphoblastic leukemia.Front Oncol2022https://conductscience.org/library/papers/36226057PubMed
35918381Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction.Sci Rep2022https://conductscience.org/library/papers/35918381PubMed
35886023Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse.Genes (Basel)2022https://conductscience.org/library/papers/35886023PubMed
35646299Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports).Ther Adv Hematol2022https://conductscience.org/library/papers/35646299PubMed
35614109The effect of apigenin and chemotherapy combination treatments on apoptosis-related genes and proteins in acute leukaemia cell lines.Sci Rep2022https://conductscience.org/library/papers/35614109PubMed
35123463A case report of pediatric acute lymphoblastic leukemia with e8a2 BCR/ABL1 fusion transcript.BMC Med Genomics2022https://conductscience.org/library/papers/35123463PubMed
35081812
Selective Ulnar Nerve Decompression, Capsular Branch Denervation, and Arthroscopic Debridement as a Unique Technique to Improve Quality of Life for Avascular Necrosis of the Distal Humerus and Radius in a Young Patient With ALL.
Hand (N Y)2022https://conductscience.org/library/papers/35081812PubMed
35013097CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia.Oncogenesis2022https://conductscience.org/library/papers/35013097PubMed
34157051Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).PLoS One2021https://conductscience.org/library/papers/34157051PubMed
34146471A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discovery.Cell Syst2021https://conductscience.org/library/papers/34146471PubMed
3387729413q12.2 deletions and FLT3 overexpression in acute leukemias.Blood Adv2021https://conductscience.org/library/papers/33877294PubMed
33363091The Current Situation and Future Trend of Leukemia Mortality by Sex and Area in China.Front Public Health2020https://conductscience.org/library/papers/33363091PubMed

See all 26 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30697448

GET https://conductscience.org/api/papers/v1/30697448/references?page=2